Nephrotic Syndrome and Statin Therapy: An Outcome Analysis.

Busuioc, Ruxandra; Ètefan, Gabriel; Stancu, Simona; Zugravu, Adrian; Mircescu, Gabriel

Busuioc, Ruxandra; Ètefan, Gabriel; Stancu, Simona; Zugravu, Adrian; Mircescu, Gabriel.

Busuioc R; Nephrology Department, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
Ètefan G; Nephrology Department, "Dr Carol Davila" Teaching Hospital of Nephrology, 010731 Bucharest, Romania.
Stancu S; Nephrology Department, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
Zugravu A; Nephrology Department, "Dr Carol Davila" Teaching Hospital of Nephrology, 010731 Bucharest, Romania.
Mircescu G; Nephrology Department, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.

Medicina (Kaunas) ; 59(3)2023 Mar 06.

Article en En | MEDLINE | ID: mdl-36984513

Asunto(s)

Enfermedades Cardiovasculares; Inhibidores de Hidroximetilglutaril-CoA Reductasas; Síndrome Nefrótico; Humanos; Masculino; Persona de Mediana Edad; Femenino; Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico; Síndrome Nefrótico/complicaciones; Síndrome Nefrótico/tratamiento farmacológico; Estudios Retrospectivos; Simvastatina

Palabras clave

end stage kidney disease; major cardiovascular events; nephrotic syndrome; remission rate; statin therapy; thrombotic complications

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Síndrome Nefrótico Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google